733
edits
Brugada Syndrome: Difference between revisions
→Medication/Other therapies:
| Line 66: | Line 66: | ||
==='''Medication/Other therapies:'''=== | ==='''Medication/Other therapies:'''=== | ||
*[ | *[Internal_Cardiac_Defibrillator ICD] implantation is first line therapy in Brugada patients with a previous cardiac arrest, [http://www.textbookofcardiology.org/index.php?title=Ventricular_Tachycardia&action=edit&redlink=1 ventricular] tachycardia or cardiac [http://www.textbookofcardiology.org/wiki/Syncope syncope]. ICD implantation in asymptomatic patients is not advised and needs careful judgement regarding the low annual rate of arrhythmic events and high incidence rate of complications (7.5 per 100 patient-years). | ||
*In Brugada patients with recurrent VF events or ICD shocks, isoproterenol or quinidine are known to be effective for VF suppression in both children and adults. | *In Brugada patients with recurrent VF events or ICD shocks, isoproterenol or quinidine are known to be effective for VF suppression in both children and adults. | ||
*Ablation of a fractionated electrogram in the epicardial right ventricular outflow tract is a promising option for VF suppression in Brugada patients in a small study, but still has to be proven in larger cohorts of Brugada patients. | *Ablation of a fractionated electrogram in the epicardial right ventricular outflow tract is a promising option for VF suppression in Brugada patients in a small study, but still has to be proven in larger cohorts of Brugada patients. | ||